Table 2.
Prevalence of dispensed benzodiazepine and opioid prescriptions among people with healthcare encounters for benzodiazepine-related toxicity, 2013 to 2020
| Measure | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | p-value |
|---|---|---|---|---|---|---|---|---|---|
| Number of benzodiazepine-related toxicity encounters | 3820 | 3856 | 3967 | 4149 | 4693 | 4487 | 3874 | 3828 | |
| Benzodiazepine prescribing history | |||||||||
| Active prescription | 2332 (61.1%) | 2419 (62.7%) | 2384 (60.1%) | 2400 (57.9%) | 2445 (52.1%) | 2434 (54.3%) | 2086 (53.9%) | 1872 (48.9%) | < 0.0001 |
| Prescription in the previous 30 days | 2417 (63.3%) | 2475 (64.2%) | 2492 (62.8%) | 2525 (60.9%) | 2621 (55.9%) | 2566 (57.2%) | 2259 (58.3%) | 2045 (53.4%) | < 0.0001 |
| Prescription in the previous 180 days | 2945 (77.1%) | 3033 (78.7%) | 3085 (77.8%) | 3123 (75.3%) | 3302 (70.4%) | 3241 (72.2%) | 2843 (73.4%) | 2571 (67.2%) | < 0.0001 |
| Active opioid prescription | 738 (19.3%) | 714 (18.5%) | 741 (18.7%) | 662 (16.0%) | 716 (15.3%) | 671 (15.0%) | 580 (15.0%) | 539 (14.1%) | < 0.0001 |
| Active opioid and benzodiazepine prescriptions | 600 (15.7%) | 569 (14.8%) | 577 (14.5%) | 500 (12.1%) | 532 (11.3%) | 507 (11.3%) | 435 (11.2%) | 391 (10.2%) | < 0.0001 |